Egyptian sweet marjoram leaves protect against genotoxicity, immunosuppression and other complications induced by cyclophosphamide in albino rats

British Journal of Nutrition

Volumn 108, Issue 6, 2012, Pages 1059-1068

  Ramadan, Gamal ^a   El Beih, Nadia M ^a   Zahra, Mai M ^a  

^a Ain Shams University   (Egypt)

Author keywords

Albino rats; Clastogenicity; Cyclophosphamide; Immunosuppression; Sweet marjoram

Indexed keywords

CATALASE; CYCLOPHOSPHAMIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HERBACEOUS AGENT; IMMUNOGLOBULIN; MALONALDEHYDE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; SWEET MARJORAM EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; CHROMOSOME ABERRATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GENOTOXICITY; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; LEUKOPENIA; LOW DRUG DOSE; LYMPHOID ORGAN; MACROCYTIC ANEMIA; MALE; MITOSIS INDEX; NONHUMAN; ORGAN WEIGHT; ORIGANUM; PLANT LEAF; POWDER; PROTECTION; RAT; SWEET MARJORAM; THROMBOCYTOPENIA;

ANIMALS; ANTIMUTAGENIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CYCLOPHOSPHAMIDE; DIETARY SUPPLEMENTS; EGYPT; IMMUNOSUPPRESSIVE AGENTS; MALE; MUTAGENS; ORIGANUM; OXIDATIVE STRESS; PLANT EXTRACTS; PLANT LEAVES; PLANT PREPARATIONS; POWDERS; PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

ORIGANUM MAJORANA; RATTUS;

EID: 84866098759     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511006210     Document Type: Article

References (49)

1. McCarroll N, Keshava N, Cimino M, et al. (2008) An evaluation of the mode of action framework for mutagenic carcinogens case study: cyclophosphamide. Environ Mol Mutagen 49, 117-131.
2. Haque R, Bin-Hafeez B, Parvez S, et al. (2003) Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity. Hum Exp Toxicol 22, 473-480.
3. Bhatia K, Kaur M, Atif F, et al. (2006) Aqueous extract of Trigonella foenum-graecum L. ameliorates additive uro-toxicity of buthionine sulfoximine and cyclophosphamide in mice. Food Chem Toxicol 44, 1744-1750.
4. Arafa HM (2009) Uroprotective effects of curcumin in cyclophosphamide- induced haemorrhagic cystitis paradigm. Basic Clin Pharmacol Toxicol 104, 393-399.
5. Anderson D, Bishop JB, Garner RC, et al. (1995) Cyclo-phosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res 330, 115-181.
6. Burgaz S, Karahalil B, Bayrak P, et al. (1999) Urinary cyclo-phosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics. Mutat Res 439, 97-104.
7. Bin-Hafeez B, Ahmad I, Haque R, et al. (2001) Protective effect of Cassia occidentalis L. on cyclophosphamide-induced suppression of humoral immunity in mice. J Ethnopharmacol 75, 13-18.
8. Zandvoort A, Lodewijk ME, Klok PA, et al. (2001) Slow recovery of follicular B cells and marginal zone B cells after chemotherapy: implications for humoral immunity. Clin Exp Immunol 124, 172-179.
9. Angulo I, Jimenez-Diaz MB, Garcia-Bustos JF, et al. (2002) Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production. Cell Immunol 218, 46-58.
10. Sharma N, Trikha P, Athar M, et al. (2000) Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of benzo[a]-pyrene and cyclophosphamide in mice. Hum Exp Toxicol 19, 377-384.
11. Haque R, Bin-Hafeez B, Ahmad I, et al. (2001) Protective effects of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Hum Exp Toxicol 20, 643-650.
12. Shukla Y, Arora A & Taneja P (2002) Antimutagenic potential of curcumin on chromosomal aberrations in Wistar rats. Mutat Res 515, 197-202.
13. Ramadan G, El-Beih NM & Badr GM (2006) Modulatory effects of aged garlic extract in comparison with fresh garlic extract: II-On induced immunosuppression and systemic anaphylaxis in male albino rats. Egypt J Zool 46, 265-283.
14. Al-Yahya AA, Al-Majed AA, Gado AM, et al. (2009) Acacia senegal gum exudate offers protection against cyclopho-sphamide-induced urinary bladder cytotoxicity. Oxid Med Cell Longev 2, 207-213.
15. Popov B, Georgieva Sv & Gadjeva V (2011) Modulatory effects of total extract of Haberlea rhodopensis against the cyclophosphamide induced genotoxicity in rabbit lymphocytes in vivo. Trakia J Sci 9, 51-57.
16. Ramadan G, El-Beih NM & Abd El-Kareem HF (2011) Anti-metabolic syndrome and immunostimulant activities of Egyptian fenugreek seeds in diabetic/obese and immuno-suppressive rat models. Br J Nutr 105, 995-1004.
17. El-Ashmawy IM, El-Nahas AF & Salama OM (2005) Protective effect of volatile oil, alcoholic and aqueous extracts of Origanum majorana on lead acetate toxicity in mice. Basic Clin Pharmacol Toxicol 97, 238-243.
18. Ghaly IS, Said A & Abdel-Wahhab MA (2008) Zizyphus jujuba and Origanum majorana extracts protect against hydro-quinone-induced clastogenicity. Environ Toxicol Pharmacol 25, 10-19.
19. Novak J, Bitsch C, Langbehn J, et al. (2000) Ratios of cis-and trans-sabinene hydrate in Origanum majorana L. and Origanum microphyllum (Bentham) vogel. Biochem Syst Ecol 28, 697-704.
20. Vagi E, Rapavi E, Hadolin M, et al. (2005) Phenolic and triterpenoid antioxidants from Origanum majorana L. herb and extracts obtained with different solvents. J Agric Food Chem 53, 17-21.
21. Jun WJ, Han BK, Yu KW, et al. (2001) Antioxidant effects of Origanum majorana L. on superoxide anion radicals. Food Chem 75, 439-444.
22. Heo HJ, Cho HY, Hong B, et al. (2002) Ursolic acid of Origanum majorana L. reduces Abeta-induced oxidative injury. Mol Cells 13, 5-11.
23. Ramadan G, El-Beih NM & Abd El-Ghffar EA (2009) Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models. Br J Nutr 102, 1611-1619.
24. Jayatilleke E & Shaw S (1993) A high-performance liquid chromatographic assay for reduced and oxidized glutathione in biological samples. Anal Biochem 214, 452-457.
25. Karatepe M (2004) Simultaneous determination of ascorbic acid and free malondialdhyde in human serum by HPLC-UV. LC GC N Am 22, 362-365.
26. Johansson LH & Borg LA (1988) A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174, 331-336.
27. Habig WH, Pabst MJ & Jakoby WB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249, 7130-7139.
28. Paglia DE & Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70, 158-169.
29. Minami M & Yoshikawa H (1979) A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta 92, 337-342.
30. El-Beih NM, Ramadan G & Badr GM (2006) Modulatory effects of aged garlic extract in comparison with fresh garlic extract: I-On induced liver toxicity and genotoxicity in male albino rats. Egypt J Zool 46, 245-264.
31. Turner JR & Thayer JF (editors) (2001) Introduction to Analysis of Variance: Design, Analysis and Interpretation. Thousand Oaks, CA: Sage Publications.
32. Boddy AV & Yule SM (2000) Metabolism and pharmaco-kinetics of oxazaphosphorines. Clin Pharmacokinet 38, 291-304.
33. Kehrer JP & Biswal SS (2000) The molecular effects of acrolein. Toxicol Sci 57, 6-15.
34. Hussain SP, Hofseth LJ & Harris CC (2003) Radical causes of cancer. Nat Rev Cancer 3, 276-285.
35. Jahangir T, Khan TH, Prasad L, et al. (2005) Pluchea lanceo-lata attenuates cadmium chloride induced oxidative stress and genotoxicity in Swiss albino mice. J Pharm Pharmacol 57, 1199-1204.
36. Lee DH, Lim BS, Lee YK, et al. (2006) Involvement of oxidative stress in mutagenicity and apoptosis caused by dental resin monomers in cell cultures. Dent Mater 22, 1086-1092.
37. Lin LT, Liu LT, Chiang LC, et al. (2002) In vitro anti-hepatoma activity of fifteen natural medicines from Canada. Phytother Res 16, 440-444.
38. Zeytinoglu H, Incesu Z & Baser KH (2003) Inhibition of DNA synthesis by carvacrol in mouse myoblast cells bearing a human N-RAS oncogene. Phytomedicine 10, 292-299.
39. Arunasree KM (2010) Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomedicine 17, 581-588.
40. Leeja L & Thoppil JE (2007) Antimicrobial activity of metha-nol extract of Origanum majorana L. (Sweet marjoram). J Environ Biol 28, 145-146.
41. Li Z, Henning SM, Zhang Y, et al. (2010) Antioxidant-rich spice added to hamburger meat during cooking results in reduced meat, plasma, and urine malondialdehyde concentrations. Am J Clin Nutr 91, 1180-1184.
42. Manesh C & Kuttan G (2005) Effect of naturally occurring isothiocyanates in the inhibition of cyclophosphamide-induced urotoxicity. Phytomedicine 12, 487-493.
43. Zhong S, Huang M, Yang X, et al. (2006) Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus. Br J Clin Pharmacol 62, 457-472.
44. Aydin S, Basaran AA & Basaran N (2005) Modulating effects of thyme and its major ingredients on oxidative DNA damage in human lymphocytes. J Agric Food Chem 53, 1299-1305.
45. Hazzit M, Baaliouamer A, Faleiro ML, et al. (2006) Composition of the essential oils of Thymus and Origanum species from Algeria and their antioxidant and antimicrobial activities. J Agric Food Chem 54, 6314-6321.
46. Mythili Y, Sudharsan PT, Sudhahar V, et al. (2006) Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy. Eur J Pharmacol 543, 92-96.
47. Liu X, Zhao J & Zheng R (2003) DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients. Mutat Res 539, 1-8.
48. Berger MM (2005) Can oxidative damage be treated nutritionally? Clin Nutr 24, 172-183.
49. Borek C (2004) Dietary antioxidants and human cancer. Integr Cancer Ther 3, 333-341.